Impact Sports Technologies receives 18th patent for mobile optical heart rate monitoring technology

NewsGuard 100/100 Score

Impact Sports Technologies, Inc., the industry leader in innovative motion resistant strapless heart rate applications, has received its 18th patent, featuring the use of its mobile optical heart rate monitoring technology with a mobile communications device. Impact Sports has 35 additional patents pending. Impact Sports Technologies' proprietary motion resistant heart rate technology and digital pedometer and activity monitor has been deployed in over two million games and fitness devices since 2010 as the company remains on the cutting edge of the current trend toward wearable computing and electronic devices. Its mobile, cost effective heart rate monitoring system is capable of tracking heart rate during heavy exercise as well as detection and monitoring of health related issues. 

Impact Sports Technologies is pursuing FDA certification for its technology and applications in the identification and monitoring of heart conditions and sleep apnea among others. Key features of the technology are its easy integration with third party platforms, low cost, simplicity and comfort. "We are on the leading edge of wearable electronics for everyday uses and heart-healthy applications with our cost-effective, readily-deployable technology," said Don Brady, President and CEO of Impact Sports Technologies. 

SOURCE Impact Sports Technologies, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Atrial fibrillation linked to high mortality and hospitalization rates, UQ study shows